MarketingRx roundup: Lundbeck’s Vyepti joins migraine TV ad battle; Pfizer debuts Covid treatment TV ad
Lundbeck debuted its first TV ad campaign for infused migraine medicine Vyepti – into an already crowded field. However, Vyepti is highlighting its unique IV delivery method that may help it stand out.
The Vyepti TV ad uses a visual effect that makes some of the people in the ad appear to be made of liquid – a 3D watery effect – that illustrates Vyepti’s liquid delivery. The watery characters are shown walking through an airport, running through the park, at work and going out to dinner as each one morphs to human form. Meanwhile, a voiceover talks about the IV treatment, highlighting its dosage – four times per year through 30-minute infusions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.